The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus

Inactivated foot-and-mouth disease virus (FMDV) vaccines have been used widely to control foot-and-mouth disease (FMD). However, the virions (146S) of this virus are easily dissociated into pentamer subunits (12S), which limits the immune protective efficacy of inactivated vaccines when the temperat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of virology 2021-08, Vol.166 (8), p.2131-2140
Hauptverfasser: Gao, Ya, Li, Pinghua, Ma, Xueqing, Bai, Xingwen, Sun, Pu, Du, Ping, Yuan, Hong, Cao, Yimei, Li, Kun, Fu, Yuanfang, Zhang, Jing, Bao, Huifang, Chen, Yingli, Li, Zhiyong, Lu, Zengjun, Liu, Zaixin, Li, Dong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Inactivated foot-and-mouth disease virus (FMDV) vaccines have been used widely to control foot-and-mouth disease (FMD). However, the virions (146S) of this virus are easily dissociated into pentamer subunits (12S), which limits the immune protective efficacy of inactivated vaccines when the temperature is higher than 30 °C. A cold-chain system can maintain the quality of the vaccines, but such systems are usually not reliable in limited-resource settings. Thus, it is imperative to improve the thermostability of vaccine strains to guarantee the quality of the vaccines. In this study, four recombinant FMDV strains containing single or multiple amino acid substitutions in the structural proteins were rescued using a previously constructed FMDV type O full-length infectious clone (pO/DY-VP1). We found that single or multiple amino acid substitutions in the structural proteins affected viral replication to different degrees. Furthermore, the heat and acid stability of the recombinant viruses was significantly increased when compared with the parental virus. Three thermally stable recombinant viruses (rHN/DY-VP1 Y2098F , rHN/DY-VP1 V2090A-S2093H , and rHN/DY-VP1 V2090A-S2093H-Y2098F ) were prepared as inactivated vaccines to immunize pigs. Blood samples were collected every week to prepare sera, and a virus neutralization test showed that the substitutions S2093H and Y2098F, separately or in combination, did not affect the immunogenicity of the virus, but the Y2098F mutation increased the thermostability significantly ( p < 0.05). Therefore, the rHN/DY-VP1 Y2098F mutant should be considered for use in future vaccines.
ISSN:0304-8608
1432-8798
DOI:10.1007/s00705-021-05100-3